Anticipating royalites from Ellavie (menopause treatment) of 15 million a year.
Based on Evamist/Ellavie sales so far, this forecast now looks massively over-optimistic. I'd be surprised if Evamist royalties from KV are as much as $1 million a year. Ellavie (Evamist in the RoW) may do better with better partners, but it seems clear the product isn't a bestseller.
One has to wonder if the forecast Axiron market might not turn out the same way...
Anticipating royalites from Ellavie (menopause treatment) of 15...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
-0.002(2.53%) |
Mkt cap ! $22.38M | |||
| Open | High | Low | Value | Volume |
| 7.8¢ | 7.9¢ | 7.7¢ | $12.27K | 156.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10092 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 9000 | 1 |
View Market Depth
| Last trade - 15.49pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
-0.002 ( 2.53 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.8¢ | 7.7¢ | 37473 | ||
| Last updated 12.58pm 14/06/2024 ? | |||||
| ACR (ASX) Chart |